The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aripiprazole 30 mg tablets

Brillpharma (Ireland) LimitedPA22749/016/005

Main Information

Trade NameAripiprazole 30 mg tablets
Active SubstancesAripiprazole
Dosage FormTablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/016/005

Group Information

ATC CodeN05AX Other antipsychotics
N05AX12 aripiprazole


License statusAuthorised
Licence Issued06/10/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0092-033-056
Interchangeable List DocumentPDF of Interchangeable List
« Back